Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease
Condition(s):Castleman Disease; Castleman’s Disease, MulticentricLast Updated:January 11, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Castleman Disease; Castleman’s Disease, MulticentricLast Updated:January 11, 2024Recruiting
Condition(s):Multicentric Castleman DiseaseLast Updated:May 30, 2023Recruiting
Condition(s):Idiopathic Multicentric Castleman’s DiseaseLast Updated:August 22, 2023Not yet recruiting
Condition(s):Idiopathic Multicentric Castleman’s DiseaseLast Updated:July 24, 2023Recruiting
Condition(s):Idiopathic Multicentric Castleman’s DiseaseLast Updated:February 9, 2021Recruiting
Condition(s):KSHV Inflammatory Cytokine Syndrome (KICS); Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman DiseaseLast Updated:March 28, 2024Not yet recruiting
Condition(s):Castleman Disease; Castleman’s Disease; Giant Lymph Node Hyperplasia; Angiofollicular Lymph Hyperplasia; Angiofollicular Lymph Node Hyperplasia; Angiofollicular Lymphoid Hyperplasia; GLNH; Hyperplasia, Giant Lymph Node; Lymph Node Hyperplasia, GiantLast Updated:December 27, 2023Recruiting
Condition(s):Human Immunodeficiency Virus; Castleman’s Disease; Kaposi’s Sarcoma; Viral-Associated CancerLast Updated:March 20, 2024Recruiting
Condition(s):Multicentric Castleman s DiseaseLast Updated:September 25, 2023Recruiting
Condition(s):Lymphoma, Primary EffusionLast Updated:March 28, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.